|
Real-time Estimate
Cboe BZX
22:06:57 16/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 6.320 USD | -0.94% |
|
-0.71% | -40.83% |
| 08-28 | Outlook Therapeutics Appoints Kevin Lundquist as CFO | MT |
| 08-14 | CapsoVision, Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
| Market Cap | 319M 277M 262M 237M 445M 30.63B 448M 3.12B 1.21B 15.54B 1.2B 1.17B 49.52B | P/E 2026 * |
-11.4x | P/E 2027 * | -14.5x |
|---|---|---|---|---|---|
| Enterprise Value | 319M 277M 262M 237M 445M 30.63B 448M 3.12B 1.21B 15.54B 1.2B 1.17B 49.52B | EV / Sales 2026 * |
21.5x | EV / Sales 2027 * | 16.1x |
| Free-Float |
67.96% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CV | Delayed | |
CBOE
| CV | Real-time | |
|
Deutsche Boerse AG
| H6U | Delayed |
Last Transcript: CapsoVision, Inc.
| 1 day | -0.94% | ||
| 1 week | -0.71% | ||
| Current month | +8.30% | ||
| 1 month | -1.86% | ||
| 3 months | -4.60% | ||
| 6 months | +23.05% | ||
| Current year | -40.83% |
| 1 week | 6.29 |  | 6.9 |
| 1 month | 5.75 | | 6.99 |
| Current year | 4.5 | | 11.37 |
| 1 year | 4.28 | | 15.37 |
| 3 years | 3.43 | | 15.37 |
| 5 years | 3.43 | | 15.37 |
| 10 years | 3.43 | | 15.37 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kang-Huai Wang
CEO | Chief Executive Officer | 69 | 01/11/2024 |
David Garcia
DFI | Director of Finance/CFO | 52 | - |
Keri Jorgenson
PRN | Corporate Officer/Principal | - | 01/03/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Kang-Huai Wang
BRD | Director/Board Member | 69 | 01/11/2024 |
Chen Lung Tsai
CHM | Chairman | 74 | 01/01/2025 |
Hui Ying Kuo
BRD | Director/Board Member | 55 | 01/02/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/07/26 | Buy | Director | 61,068 | 0.1225% | ||
| 08/07/26 | Buy | Director | 81,300 | 0.1631% | ||
| 01/07/26 | Free | Director | 1,710 | 0.0034% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.94% | -0.71% | +41.18% | - | 319M | |
| -0.49% | -5.13% | -33.22% | -4.51% | 12.42B | |
| +2.29% | 0.00% | +16.90% | +10.17% | 4.18B | |
| +1.61% | -10.53% | -47.04% | -60.77% | 1.17B | |
| -0.20% | -6.04% | -45.96% | -45.26% | 1.05B | |
| +0.47% | -0.79% | +16.01% | +77.74% | 1.05B | |
| +2.36% | -4.35% | - | - | 965M | |
| +0.66% | -5.47% | -39.65% | - | 964M | |
| +1.14% | -4.28% | +32.56% | +100.31% | 500M | |
| -1.97% | -5.97% | -69.92% | +314.29% | 232M | |
| Average | +0.49% | -0.12% | -14.35% | +56.00% | 2.29B | |
| Weighted average by Cap. | +0.37% | -0.56% | -20.71% | +3.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.87M 12.89M 12.18M 11.06M 20.73M 1.43B 20.85M 145M 56.19M 724M 55.87M 54.63M 2.31B | 19.82M 17.18M 16.24M 14.74M 27.63M 1.9B 27.79M 194M 74.9M 965M 74.46M 72.81M 3.07B |
| Net income | -27.56M -23.88M -22.57M -20.49M -38.4M -2.64B -38.63M -269M -104M -1.34B -104M -101M -4.27B | -22.1M -19.15M -18.1M -16.43M -30.8M -2.12B -30.98M -216M -83.5M -1.08B -83.02M -81.18M -3.43B |
| Net Debt | - | - |
Employees
99
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/09/26 | $6.325 | -0.86% | 192,721 |
| 15/09/26 | $6.380 | -2.00% | 250,549 |
| 14/09/26 | $6.510 | -1.36% | 224,553 |
| 11/09/26 | $6.600 | +1.23% | 207,060 |
| 10/09/26 | $6.520 | +2.35% | 163,623 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.380USD
Average target price
9.500USD
Spread / Average Target
+48.90%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CV Stock
Select your edition
All financial news and data tailored to specific country editions
